#ScienceSaturday: February 24, 2024

#ScienceSaturday: February 24, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research A Model for Chemomechanical Coupling of Kinesin‑3 Motor Like humans, KIF1A pairs walk one step at a time,…

Read More
#ScienceSaturday: February 17, 2024

#ScienceSaturday: February 17, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research Overarching pathomechanisms in inherited peripheral neuropathies, spastic paraplegias, and cerebellar ataxias What causes KAND? At the simplest level,…

Read More
#ScienceSaturday: February 10, 2024

#ScienceSaturday: February 10, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research Unraveling the genetic landscape of undiagnosed cerebellar ataxia in Brazilian patients In this week’s article, researchers in Brazil…

Read More
#ScienceSaturday: February 3, 2024

#ScienceSaturday: February 3, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research Large-Scale Whole-Genome Analysis of HTLV-1–Associated Myelopathy Identified Hereditary Spastic Paraplegias Many disorders look similar to each other when…

Read More
Harrison’s Superhero Story

Harrison’s Superhero Story

“Harrison is the most amazing little boy who makes us all so proud everyday. He is very determined and independent, he loves school, absolutely loves the outdoors, and has a wonderful brother and sister who support him at all times.”

Read More
January 2024

January 2024

Bidding Sean Calamia a Farewell! Dear Sean, As you embark on a new chapter in your journey, we want to express our heartfelt gratitude for your unwavering dedication and contributions to KIF1A.ORG and our warriors. Your tireless efforts have made a profound impact on our community, and your passion for supporting KAND patients and families…

Read More
#ScienceSaturday: January 27, 2024

#ScienceSaturday: January 27, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Rare Roundup KRIBB develops new gene therapy candidate for hereditary spastic paraplegia This week we’re flipping the format and starting…

Read More
#ScienceSaturday: January 20, 2024

#ScienceSaturday: January 20, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KAND Resources KAND is a complex disorder, and each patient may experience a wide variety of symptoms that require evaluation…

Read More
#ScienceSaturday: January 13, 2024

#ScienceSaturday: January 13, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research A two-kinesin mechanism controls neurogenesis in the developing brain As we bring in the New Year with this…

Read More
November 2023 Highlights

November 2023 Highlights

New Address! 1178 Broadway, 3rd Floor #3535, New York, New York, 10001 Please send all KIF1A.ORG mail (including donation checks) here! Thank you. November is Epilepsy Awareness Month #GivingTuesday is November 28th~ Clinical Conversations: Speech and Communication in KAND  Sunday, December 3 at 5:00pm EST US Families Survey: Health Policy and Advocacy KIF1A is working…

Read More
#ScienceSaturday: November 11, 2023

#ScienceSaturday: November 11, 2023

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy Overlap between KAND and…

Read More